Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Exchange Rate Effect: 2024-2025

Historic Exchange Rate Effect for SAB Biotherapeutics (SABS) over the last 2 years, with Sep 2025 value amounting to -$37,537.

  • SAB Biotherapeutics' Exchange Rate Effect fell 178.96% to -$37,537 in Q3 2025 from the same period last year, while for Sep 2025 it was -$104,384, marking a year-over-year change of. This contributed to the annual value of -$241,198 for FY2024, which is 1429.35% down from last year.
  • SAB Biotherapeutics' Exchange Rate Effect amounted to -$37,537 in Q3 2025, which was down 120.92% from $179,401 recorded in Q2 2025.
  • Over the past 5 years, SAB Biotherapeutics' Exchange Rate Effect peaked at $179,401 during Q2 2025, and registered a low of -$288,748 during Q4 2024.
  • Moreover, its 2-year median value for Exchange Rate Effect was $28,283 (2024), whereas its average is -$8,119.
  • The largest annual percentage gain for SAB Biotherapeutics' Exchange Rate Effect in the last 5 years was 534.31% (2025), contrasted with its biggest fall of 178.96% (2025).
  • Over the past 2 years, SAB Biotherapeutics' Exchange Rate Effect (Quarterly) stood at -$288,748 in 2024, then slumped by 178.96% to -$37,537 in 2025.
  • Its last three reported values are -$37,537 in Q3 2025, $179,401 for Q2 2025, and $42,500 during Q1 2025.